The effect of chronic tianeptine administration on the brain mitochondria : direct links with an animal model of depression by Głombik, Katarzyna et al.
The effect of chronic tianeptine administration on the brain
mitochondria: direct links with an animal model of depression
Katarzyna Głombik1 & Aneta Stachowicz2 & Rafał Olszanecki2 & Joanna Ślusarczyk1 &
Ewa Trojan1 & Władysław Lasoń1 & Marta Kubera1 & Bogusława Budziszewska1 &
Michael Spedding3 & Agnieszka Basta-Kaim1
Received: 23 November 2015 /Accepted: 18 February 2016 /Published online: 2 March 2016
# The Author(s) 2016. This article is published with open access at Springerlink.com
Abstract A growing body of evidence has focused on the
impact of mitochondrial disturbances in the development of
depression, but little data exist regarding the effects of chronic
administration of antidepressant drugs on the brain’s mito-
chondrial protein profile. The aim of this study was to inves-
tigate the impact of chronic treatment with an atypical antide-
pressant drug—tianeptine—on the mitochondria-enriched
subproteome profile in the hippocampus and the frontal cortex
of 3-month-old male rats following a prenatal stress proce-
dure. Rats that were exposed to a prenatal stress procedure
displayed depressive- and anxiety-like disturbances based on
the elevated plus-maze and Porsolt tests. Moreover, two-
dimensional electrophoresis coupled with mass spectrometry
showed structure-dependent mitoproteome changes in brains
of prenatally stressed rats after chronic tianeptine administra-
tion. A component of 2-oxoglutarate and succinate flavopro-
tein subunit dehydrogenases, isocitrate subunit alpha, was up-
regulated in the hippocampus. In the frontal cortex, there was
a striking increase in the expression of glutamate dehydroge-
nase and cytochrome bc1 complex subunit 2. These findings
suggest that mitochondria are underappreciated targets for
therapeutic interventions, and mitochondrial function may be
crucial for the effective treatment of stress-related diseases.
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Introduction
There exist well-established theories of depression that are
based on monoamine transmission, immune system dysfunc-
tion, the weakened action of neurotropic factors, and hyperac-
tivity of the hypothalamus-pituitary-adrenal (HPA) axis.
Recently, another interesting theory called Bthe mitochondrial
dysfunction hypothesis^ has been highlighted [1, 2]. Impaired
function of mitochondria leads to bioenergetic malfunctions,
diminished adenosine triphosphate (ATP) production, im-
paired calcium homeostasis, and the enhanced production of
free radicals and oxidative stress, leading to the initiation of
apoptotic processes [3]. Furthermore, mitochondria in the cen-
tral nervous system (CNS) may control processes of
neuroplasticity, including neural differentiation, neurite out-
growth, dendritic remodeling, and neurotransmitter release
[4]. Some data also suggested the interaction of mitochondrial
function with epigenetic processes that are important in the
pathogenesis of neuropsychiatric disorders, including depres-
sion symptoms [5]. All of these observations indicate that
mitochondrial malfunctions may be a crucial factor in meta-
bolic disturbances leading to depression [2].
In agreement with this theory, the following phenomena
have been observed in depression: changes in mitochondrial
morphology, decreases in mitochondrial respiration, increases
in the polymorphisms in mitochondrial DNA (mtDNA) and
the level of mtDNA mutations, as well as the downregulation
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of nuclear mRNAs and the proteins engaged in mitochondrial
respiration. Moreover, electron microscopy data have demon-
strated alterations in the number of mitochondria and their
distribution in brain areas that are important in the pathogen-
esis of these diseases [6]. Decreased levels of high-energy
phosphates and a diminished pH in the brains of depressive
patients have generally been observed [7].
Therefore, mitochondria may be an interesting target for
therapeutic intervention. An improvement in mitochondrial
function could represent a crucial component in the effective
treatment of stress-related diseases [8].
Tianeptine, an atypical antidepressant, seems to be most
interesting and promising among the antidepressant drugs;
however, the molecular mechanism of tianeptine action is still
controversial. The neurochemical properties of tianeptine differ
from those of other tricyclic and nontricyclic antidepressants.
While classic tricyclic antidepressants and selective serotonin
reuptake inhibitors (SSRI) block serotonin reuptake, tianeptine
was shown to selectively enhance serotonin uptake into rat
brain synaptosomes [9]. Tianeptine may also have properties
related to its effect on the glutamatergic system and the reversal
of stress-associated impaired neuroplasticity [10]. Moreover,
the anticonvulsant and analgesic effects of tianeptine have been
postulated [9]. So far, only a few in vitro studies have investi-
gated the influence of tianeptine on isolated mitochondria [11].
Tianeptine inhibits complex I activity in vitro, but other mito-
chondrial complexes, apoptotic processes, and membrane po-
tential reductions were not affected by this drug [3]. However,
Della [12] observed in adult, maternally deprived rats that
chronic tianeptine administration leads to a decrease in the
creatinine concentration in the amygdala and the hippocampus
and modulated the levels of mitochondrial complex I and com-
plex II/III of the respiratory chain.
To the best of our knowledge, there are no data concerning
the effect of chronic tianeptine treatment on the expression of
the brain’s mitochondrial protein profile in an animal model of
depression. The mitochondrial pathology in depression may
result from, among other reasons, early adverse life experi-
ences affecting brain development. Therefore, in the present
study, we used one of the well-characterized animal models of
depression, the prenatal stress procedure. In this model, be-
havioral disturbances and abnormalities in the functioning of
the immune and neuroendocrine systems have been observed
[13–18]. Furthermore, our previous study showed that stress
during pregnancy may lead to disturbances in both mitochon-
drial biogenesis in the brain as well as in the mitoproteome in
adult offspring [19].
In the present study, we applied two-dimensional electro-
phoresis coupled with mass spectrometry to investigate the
influence of chronic administration of the atypical antidepres-
sant drug tianeptine on the changes in the mitochondrial pro-
teomic expression profile in the brain areas affected by prena-
tal stress and with major importance in the pathogenesis of
depression, namely, the hippocampus and the frontal cortex of
adult 3-month-old male rats.
Materials and methods
Animals
Sprague–Dawley rats (200–250 g upon arrival) were obtained
from Charles-River Laboratories (Germany) and were main-
tained under standard conditions. Vaginal smears from the
female rats were taken daily to determine the phase of the
estrous cycle. On the day of proestrus, females were placed
with males for 12 h and the presence of sperm in vaginal
smears was confirmed the next morning. Pregnant females
were randomly assigned to the control and stress groups
(n=8 per group).
All experiments were performed in accordance with the
National Institutes of Health Guide for the Care and Use of
Laboratory Animals and were approved by the Local Ethics
Committee, Kraków, Poland (permit no. 699,18.01.2010).
Stress procedure
The prenatal stress procedure was performed as described pre-
viously [13, 15, 17]. Briefly, the pregnant females were sub-
jected to three stress sessions daily beginning on the 14th day
of pregnancy and continuing until delivery. At 9:00 am, 12:00
pm, and 5:00 pm, the rats were placed in plastic cylinders
(7/12 cm) and exposed to a bright light (150 W) for 45 min.
Control pregnant females were left undisturbed in their
home cages. Only offspring from litters containing eight
to ten pups with a similar number of males and females
were included in the study. Male offspring were selected
for the experiment from 21-day-old litters. These rats
were housed in groups of four animals per cage (one
to two animals from each litter). At 3 months of age, the
offspring of control and stressed mothers underwent the first
behavioral verification.
Elevated plus-maze test
The elevated plus-maze test was performed according to a
method described previously by Pellow [20] in control and
prenatally stressed rats (n=18 each group). The maze was
elevated to a height of 50 cm above the floor and illuminated
only with a dim light from beneath. The animals were
placed in the experimental room for 1 h before the test.
Each animal was placed in the central area of the maze
facing the closed arm and observed for a total of 5 min.
The results are presented as the average number of en-
tries into the open and the closed arms of the maze and the
average time spent in each.
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Forced swim test (FST, Porsolt test)
For further verification of the animal model of depression, the
forced swim test was conducted according to the meth-
od described previously [16, 21]. Briefly, the animals
(n= 18 each group) were individually subjected to two
trials, during which they were forced to swim in a cyl-
inder filled with water (25 °C) to a height of 35 cm.
There was a 24-h interval between the first and the
second trial. The first trial lasted 15 min, and the sec-
ond trial lasted 5 min. The total durations of immobility,
mobility (swimming), and climbing were measured during the
second trial [21, 22].
For pharmacological verification of the animal model of
depression, animals underwent the elevated plus-maze and
forced swim procedure again on the last days of chronic anti-
depressant drug treatment (according to the schedule illustrat-
ed in Fig. 1).
Antidepressant drug administration
After the behavioral verification, the control and prenatally
stressed offspring were divided into six experimental groups
(CONTROL+VEH, CONTROL+ IMI, CONTROL+TIA,
STRESS+VEH, STRESS+ IMI, STRESS+TIA; six animals
per group) and were treated for 21 days with antidepressant
drugs or vehicle. Imipramine (used as a reference drug to
compare tianeptine efficiency in behavioral tests; Sigma-
Aldrich, St. Louis, MO, USA), tianeptine (Servier, France)
or vehicle (0.9 % saline, Polpharma, Poland) was injected
intraperitoneally, once per day between 9:00 am and
10:00 am. Imipramine and tianeptine were injected at
a dose of 10 mg/ml/kg in a volume of 1 ml/kg. Twenty-four
hours after the last injection, the animals were sacrificed by
rapid decapitation. The hippocampi and the frontal cortices
were dissected.
Subcellular fractionation
A mitochondria-enriched fraction was isolated at 4 °C from
freshly harvested brain structures. Brain structures were ho-
mogenized in a solution of 250 mM sucrose and 1 mM
EGTA, pH 7.8 with the addition of 1 mM PMSF and a
protease inhibitor mixture (Sigma, USA). Nuclei and
unbroken cells were pulled down by centrifugation at
1000 g for 10 min. Then, the mitochondrial fraction
was obtained by centrifugation of the supernatant at
12,000 g for 10 min. The mitochondria-enriched pellet
was then purified using 3 cycles of resuspension, ho-
mogenization, and centrifugation (at 12,000 g for 15,
20, and 15 min). The cytosolic fraction was obtained
by further centrifugation of the supernatant (90 min at
125,000 g, 4 °C).
2-DE and gel image analysis
Mitochondria-enriched pellets were resuspended in 0.5 ml of
lysis buffer containing 7 M urea, 2 M thiourea, 4 % CHAPS,
1 % DTT, 0.5 % Bio-Lyte 3–10 (Bio-Rad, USA) and a prote-
ase inhibitor mix. Samples were vortexed and incubated at
25 °C for 30 min to ensure maximal protein solubilization;
samples were then centrifuged at 12,000g for 15 min. The
supernatant was harvested, and the protein concentration
was determined [23]. The supernatant was divided into ali-
quots containing an appropriate amount of protein for single
IPG strips (300 μg for analytical gels). Samples were purified
by precipitation using the two-dimensional electrophoresis (2-
DE) Clean-up kit (GE Healthcare, USA) and resuspended in
450 μl of rehydration buffer (7 M urea, 2 M thiourea, 4 %
CHAPS, 1.2 % DeStreak Reagent (GE Healthcare, USA), and
0.5 % Bio-Lyte 3–10). Then, samples were loaded onto 24-
cm, nonlinear 3–10 immobilized pH gradient strips (Bio-Rad,
USA) using an in-gel rehydrationmethod andwere rehydrated
overnight in a reswelling tray. The strips were focused with a
multistep voltage gradient of 150 to 6000 V (max 50 mA/IPG
strip, 20 °C) for a total of 100 kVh. Once IEF was completed,
the strips were equilibrated in buffer (6M urea, 30% glycerol,
2 % SDS, and 0.01% bromophenol blue) with addition of 1%
w/v DTT (20 min) and 4.8 % w/v iodoacetamide (20 min) to
ensure sufficient reduction and alkylation of proteins. The
second dimension was obtained using a 9–16 % gradient
SDS-PAGE gel without a stacking gel using the Protean
Plus Dodeca Cell system (Bio-Rad, USA). After electropho-
resis, the gels were fixed overnight in an ethanol/acetic
acid/water solution (4:1:5 v/v/v). Finally, protein profiles were
visualized by silver staining using the Plus One silver staining
kit (GE Healthcare, USA) with modifications to provide com-
patibility with subsequent mass spectrometry analysis [24].
Silver-stained gels were imaged using a GS 800 densitometer
(Bio-Rad, USA). PDQuest™ 8.0.1 (Bio-Rad, USA) was used
for gel image analysis, quantification, and statistical valida-
tion. In total, n=3 gel images representing each group from
the total number of n=2 replicates of two individual samples
(n=6 gel images per group) were analyzed. All results were
carefully verified manually, including the verification of
housekeeping proteins chosen for normalization (local regres-
sion model) to ensure accurate quantification. Significant dif-
ferences were further analyzed with an LC MS/MS system to
identify proteins of interest.
LC MS/MS
Gel pieces containing protein spots of interest were destained,
reduced, alkylated, and digested with modified trypsin
(Promega) according to the protocol described by
Shevchenko [25]. Peptide maps were lyophilized and stored
at −80 °C for further LC/MS analysis. Each sample was
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resuspended in 0.1 % FA and injected onto an Acclaim
PepMap100 RP C18 75 μm (i.d.)× 15 cm column (Thermo
Scientific) via a trap column (Acclaim PepMap100 RP C18
75 μm (i.d.) × 2 cm column, Thermo Scientific).
Peptides were separated over 55 min in a 7–55 % B
phase linear gradient (A phase—2 % ACN and 0.1 %
formic acid; B phase—80 % ACN and 0.1 % formic acid)
with a flow rate of 300 ml/min using a Switchos/UltiMate
3000 HPLC system (LC Packings/Thermo Scientific) and ap-
plied on-line to a Velos Pro (Thermo Scientific) ion-trap mass
spectrometer. The main working liquid-junction nanoESI ion
source parameters were as follows: capillary voltage, 1.7 kV,
and capillary temperature, 250 °C. Spectra were collected in
full-scan mode (400–1500 Da); five MS/MS scans were then
performed of the five most intensive ions from the full scan
using dynamic exclusion criteria. Collected MS/MS data were
analyzed by the X! Tandem search algorithm (The GPM
Organization) and statistically validated with Peptide and
Protein Prophet (Trans-Proteomic Pipeline, Institute for
Systems Biology).
Immunoblotting
The purity of the fractions was assessed by immunoblotting of
cytochrome c oxidase (COX-IV) and cyclophilin A. The iso-
lated mitochondria-enriched fraction was lysed in PBS con-
taining 1 % Triton X-100, 0.1 % SDS, 1 mM PMSF, 100 μM
leupeptin, and 50 μM pepstatin A. Samples containing equal
amounts of total protein were mixed with gel loading buffer
(50 mM Tris, 10 % SDS, 10 % glycerol, 10 % 2-
mercaptoethanol, and 2 mg/ml bromophenol blue) in a 4:1
ratio (v/v) and incubated at 95 °C for 5 min. Samples were
separated on SDS-polyacrylamide gels (Mini Protean II, Bio-
Rad, USA) using the Laemmli buffer system, and proteins
were semidry-transferred to nitrocellulose membranes
(Amersham Biosciences, USA). Membranes were blocked
overnight at 4 °C with 5 % nonfat dried milk in TTBS and
incubated for 3 h at room temperature with specific primary
antibodies: 1:5000 ANTI-COX4, 1:1:000 ANTI-Cyclophilin
A (Abcam, USA). Membranes were then incubated for 1 h
with HRP-conjugated secondary antibodies (Amersham
Biosciences, USA). Bands were developed with the use of
ECL-system reagents (Amersham Biosciences, USA).
Protein pattern images were taken using a LAS-500 scanner
(GE Healthcare, USA).
Statistical analysis
The statistical analyses were performed with Statistica 10.0
software (Statsoft, Tulsa, USA). The outcomes of behavioral
studies are presented as the mean±SEM. The behavioral data
were analyzed using one-way or two-way analysis of variance
(ANOVA) with prenatal stress and treatment as the factors, and
p values lower than 0.05 were regarded as statistically signifi-
cant. The significance of differences between the means was
evaluated by Duncan’s test. ANOVA assumptions (normality
of variable distribution and homogeneity of variances) were
assessed by the Shapiro-Wilk and Levene tests, respectively.
The Student’s t test was used to reveal statistically significant
differences in the expression of mitochondrial proteins.
Results
Impact of chronic tianeptine administration
on the anxiety-like behavior of prenatally stressed rats
The elevated plus-maze test was used to assess anxiety-like
behavior in rats. As expected, as shown in Table 1, the prena-
tal stress procedure caused a significant reduction in the num-
ber of entries into the open arms (F1,34=32.46; p<0.05) of
the maze and a significant decrease in the time spent in them
(F1,34=88.57; p<0.05). However, we did not observe differ-
ences in the number of entries to the closed arms and the time
spent in them. Next, to determine whether chronic tianeptine
or imipramine (as a reference drug to compare with tianeptine)
administration affected the anxiety-like behavior evoked by
the prenatal stress, we assessed the elevated plus-maze test
again. As in the first set of experiments, in prenatally stressed
rats, we observed a reduction in the number of entries into the
open arms of the maze (F1,30=4.67) and a significant de-
crease in the time spent in them (F1,30=4.17). Moreover,
we found a significant effect of drugs (F2,30 = 4.32;
p< 0.05) and the stress × drug interaction (F2,30 = 3.60;
* After Porsolt test animals were treated with the last dose of antidepressants  
Pre-test Porsolt 
test 
Elevated 
plus-maze 
Pre-test Porsolt 
test * 
21 days of treatment 
Decapitation 
Day 21 Day 18 Day 20 
Fig. 1 Schematic diagram representing the schedule of the experiment
7354 Mol Neurobiol (2016) 53:7351–7362
p<0.05) for the number of visits into the open arms (Fig. 2a)
as well as a significant effect of drugs (F2,30=21.48; p<0.05;
Fig. 2a) and the stress × drug interaction (F2,30 = 25.14;
p< 0.05; Fig. 2a, b) for the time spent in the open arms.
Post hoc comparisons showed that both imipramine (p<0.05)
and tianeptine (p<0.05) normalized the number of entries into
the open arms of the maze and the time spent in them
(p<0.05).
Impact of chronic tianeptine administration
on the depressive-like behavior of prenatally stressed rats
To evaluate the depression-like behavior in rats, we performed
the forced swim test (Porsolt test). We confirmed [16] that the
prenatal stress procedure caused significantly prolonged immo-
bility (F1,34=569.01; p<0.05) and shortened swimming (F1,
34=569.83; p<0.05) and climbing (F1,34=29.95; p<0.05)
times (Table 1). In the next set of experiments, we determined
the effects of chronic tianeptine and imipramine (as a reference)
administration on the behavioral changes evoked by the prena-
tal stress by performing the Porsolt test again. We observed an
increase in the immobility (F1,30=31.16; p<0.05) and a de-
crease in swimming (F1,30=24.77; p<0.05) and climbing
(F1,30 = 25.76; p< 0.05) times, which confirmed that the
changes induced by the prenatal stress procedure are long last-
ing (Fig. 2e, f, g). Furthermore, we observed a significant effect
of the drugs (F2,30=99.43; p<0.05; Fig. 2e) and the stress ×
drug interaction (F2,30=86.05; p<0.05; Fig. 2e) on the immo-
bility time. Post hoc comparisons revealed that imipramine
(p<0.05) and tianeptine (p<0.05) shortened the immobility
time in prenatally stressed offspring. Additionally, for swim-
ming time, we observed a significant effect of drugs (F2,
30=141.65; p<0.05; Fig. 2f) and the stress × drug interaction
(F2,30=121.18; p<0.05; Fig. 2f). Post hoc comparisons re-
vealed that imipramine (p<0.05) and tianeptine (p<0.05)
extended the swimming time in the offspring of stressed rats.
Importantly, only tianeptine (p<0.05) prolonged the climbing
time in prenatally stressed rats (Fig. 2g).
Impact of chronic tianeptine administration
on the mitochondria-enriched subproteome
in the hippocampus and the frontal cortex of prenatally
stressed rats
We investigated the influence of tianeptine on mitochondrial
protein expression in the selected brain areas using 2-DE
coupled with tandem mass spectrometry. The representative
2-DE gel images of the mitochondrial proteins from the pre-
natally stressed animals treated with tianeptine, as well as
selected pairs of spots showing the differences between the
prenatally stressed offspring and prenatally stressed animals
treated with tianeptine, are presented for the hippocampus and
the frontal cortex (Fig. 3). The LC MS/MS analysis from the
numbered spots and the associated differences are listed in
Table 2. Quantitation of the significant differences in the ex-
pression of the mitochondrial proteins is shown in Fig. 4a, b.
The accuracy of the isolation protocol and the purity of the
mitochondrial fractions were assessed by immunoblotting for
cyclophilin A and COX-IV (Fig. 3).
Briefly, in the hippocampus, 16 differentially expressed
spots were detected in the samples from prenatally stressed
rats treated with tianeptine. As shown in Table 2, the expres-
sion of 14 proteins was increased; these increased proteins
included metabolic enzymes (e.g., isocitrate dehydrogenase
[NAD] subunit alpha, +2.97-fold change; NADH dehydroge-
nase iron-sulfur protein 4, +2.1-fold change; succinate dehy-
drogenase flavoprotein subunit, +1.98-fold change; and a
component of the 2-oxoglutarate dehydrogenase complex,
+1.81-fold change) and heat shock proteins (HSP70, +1.99-
fold change and HSP60, +1.65-fold change). In the frontal
cortex of the prenatally stressed offspring that underwent
chronic tianeptine administration, we identified only three dif-
ferentially expressed spots using PDQuest™, which were an-
alyzed by mass spectrometry. Among them, two spots were
upregulated (cytochrome b-c1 complex subunit 2, +2.86-fold
change and glutamate dehydrogenase 1, +2.37-fold change)
and one was downregulated (cell division control protein 42
homolog, −1.75-fold change).
Protein clusters in the hippocampus and the frontal cortex
were identified according to GO Annotation by the Search
Tool for the Retrieval of Interacting Genes (STRING, version
10) database (http://string-db.org) using Bmolecular function,^
Bbiological processes,^ or Bcellular component^ as a criterion.
The STRING database integrates interaction data from several
bioinformatics sources and provides information about
physical and functional properties as well as known and
predicted interactions of genes and their products. The
analysis did not show any correlation between proteins in the
Table 1 The effect of prenatal stress on the number of visits and the
time spent in the open and the closed arms in the elevated plus-
maze and on the times for immobility, swimming, and climbing in the
forced swim test
Elevated plus-maze
Control Stress
Number of visits in the open arms 3.3 ± 0.3 1.5 ± 0.5*
Time spent in the open arm [s] 15.1 ± 1.0 5.2 ± 0.4*
Number of visits in the closed arms 7.5 ± 1.1 8.5 ± 0.8
Time spent in the closed arm [s] 180 ± 20.1 212 ± 10.0
Forced swim test
Immobility [s] 99.4 ± 5.1 264.8 ± 4.7*
Swimming [s] 199.9 ± 5.1 35.2 ± 4.7*
Climbing [s] 40.2 ± 4.1 15.2 ± 1.9*
The results are presented as the mean± SEM, *p< 0.05, n = 18 for each
group, one-way ANOVA
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frontal cortex. However, in the hippocampus, an analysis using
molecular function as a criterion revealed a strong correlation
between eight proteins. Furthermore, in the hippocampus,
correlations of all proteins were observed using cellular
component as a criterion, clearly confirming the purity of the
samples that were subjected to proteomic analysis. In Fig. 4c,
we show a screenshot from the bioinformatics analysis and the
associations between proteins in the hippocampus.
Discussion
Recent studies [2] have noted that the brain functions at the
limit of its energy supply, which can limit neuronal activity.
Furthermore, trophic stimuli such as brain-derived neuro-
trophic factor (BDNF) increase brain mitochondrial efficien-
cy; however, this effect is blocked by inflammatory cytokines
[26], which can contribute to depression. Mitochondrial dis-
ease leads to debilitating fatigue [27], mitochondrial DNA
changes, and oxidative damage have been reported in patient
cohorts with depression [28]; therefore, mitochondrial func-
tion may be compromised in some forms of depression.
Our study demonstrated, for the first time, that chronic
administration of the atypical antidepressant drug tianeptine
not only normalized the behavioral disturbances in adult pre-
natally stressed animals but also affected the protein expres-
sion profile in brain mitochondria. These effects involved the
critical rate-limiting enzymes in the Krebs cycle, predomi-
nantly in the hippocampus and to a lesser extent in the frontal
cortex of adult male offspring.
The prenatal stress procedure is a well-established animal
model of depression, whose predictive, face and construct
validity have already been documented [29, 30]. In the present
study, the behavioral tests were used for verification of
tianeptine efficiency, while imipramine, a tricyclic antidepres-
sant drug, was applied only as a reference drug for comparison
with the behavioral efficacy of tianeptine. We confirmed that
Fig. 2 The effects of prenatal stress and chronic imipramine or tianeptine
administration on the number of visits (a) and the time spent (b) in the
open arms of the elevated plus-maze and the number of visits (c) and the
time spent (d) in the closed arms of the elevated plus-maze. The effects of
prenatal stress and chronic imipramine or tianeptine administration on the
immobility (e), the swimming (f), and the climbing (g) times (in seconds)
in the forced swim test. The data are presented as the means ± SEMs, with
n = 6 for each group, ANOVA (two-way), followed by Duncan’s test.
*p ≤ 0.05 compared with the control Veh group; #p ≤ 0.05 compared
with the prenatally stressed Veh group
Fig. 3 Representative 2-D map of the mitochondrial proteins expressed in
the hippocampus (a) and the frontal cortex (b) of prenatally stressed rats
treated with tianeptine compared with Those of prenatally stressed rats, with
magnifications of spot pairs corresponding to NADH dehydrogenase iron-
sulfur protein 4, succinate dehydrogenase flavoprotein subunit, and
cytochrome b-c1 complex subunit 2. The purity of the mitochondrial
fraction was assessed by Western blotting, which showed the absence of
cytosolic cyclophilin A in the mitochondrial fraction
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adult male rats born to dams exposed to stress during the third
trimester of pregnancy displayed a prolonged immobility time
in the forced swimming test and shortened swimming and
climbing times [15]. The present study showed that chronic
tianeptine administration normalized all of the parameters
evaluated in the Porsolt test. Furthermore, tianeptine adminis-
tration attenuated the anxiety-like behavior evoked by prenatal
stress as assessed by an increase in the number of entries and
in the time spent in the open arms of the maze.
Chronic treatment with tianeptine modulated mitoproteomic
changes in the hippocampus and the frontal cortex after the
prenatal stress procedure [19]. A growing body of evidence
suggests that mitochondrial disturbances play a key role in
the pathogenesis of depression [19, 31], but the impact of
chronic tianeptine administration on the mitochondria-
enriched subproteome in both the hippocampus and the frontal
cortex in an animal model of depression had not been investi-
gated so far. With regard to the hippocampus, the upregulated
expression of isocitrate dehydrogenase (IDH) after chronic
tianeptine administration appears to be themost striking finding
of our study. So far, there are no data showing the impact of
antidepressants on the mitochondrial expression of this rate-
limiting Krebs cycle enzyme. Importantly, our data demonstrat-
ed that chronic tianeptine administration in prenatally stressed
offspring increased the expression of a component of the
2-oxoglutarate dehydrogenase complex (OGDHC). The
OGDHC comprises multiple copies of three catabolic compo-
nents, the action of which is required for an important regula-
tory step in the mitochondrial Krebs cycle (the oxidative decar-
boxylation of 2-oxoglutarate, which generates energy in the
form of NADH and the macroergic compound succinyl-CoA)
[32]. Some data demonstrated that malfunction of the OGDHC
associated with mitochondrial dysfunction might be a crucial
point in the pathogenesis of depression [33]. Consistent with
this finding, the stimulation of the brain OGDHC complex by a
synthetic analog of 2-oxoglutarate upregulated the activity of
this enzymatic complex and affected behavioral changes,
which were expressed as an increase in exploratory activity
and diminished anxiety behavior in rats [32]. Based on this
observation, it may be postulated that the ability of tianeptine
Table 2 Differentially expressed proteins in the hippocampus (A) and the frontal cortex (B) of prenatally stressed rats treated with tianeptine compared
with prenatally stressed rats
No. Protein UniProtKB
accession number
Molecular
mass (Da)
pIa Unique
peptides
Total
peptides
Protein
coverage (%)
Fold
change
(A) Hippocampus
1 3′(2′),5′-bisphosphate nucleotidase 1 (Bpnt1) Q9Z1N4 33,153 5.58 5 21 17.9 % 4,12
2 Isocitrate dehyd [NAD] subunit alpha (Idh3a) Q99NA5 39,588 6.46 3 6 7.9 % 2,97
3 T-complex protein 1 subunit beta (Cct2) Q5XIM9 57,422 6.01 9 18 16.8 % 2,5
4 Transitional endoplasmic reticulum ATPase (Vcp) P46462 89,293 5.14 11 30 17.0 % 2,31
5 NADH dehydrogenase iron-sulfur protein 4 (Ndufs4) Q5XIF3 19,728 10.14 2 8 11 % 2,1
6 Heat shock-related 70 kDa protein 2 (Hspa2) P14659 69,599 5.51 2 11 3.8 % 1,99
7 Succinate dehydrogenase flavoprotein subunit (Sdha) Q920L2 71,570 6.75 5 34 9.2 % 1,98
8 Component of 2-oxoglutarate dehydrogenase complex (Dlst) Q01205 48,894 8.89 4 17 7.0 % 1,81
9 60 kDa heat shock protein (Hspd1) P63039 60,917 5.91 15 39 32.3 % 1,65
10 Pyruvate kinase isozymes M1/M2 (Pkm) P11980 57,781 6.63 8 18 22 % 1,53
11 Clathrin light chain B (Cltb) P08082 25,102 4.56 5 14 17.9 % 1,47
12 Clathrin light chain A (Clta) P08081 26,964 4.41 3 37 10.5 % 1,38
13 WD repeat-containing protein 1 (Wdr1) Q5RKI0 66,140 6.15 6 20 10.4 % 1,33
14 Septin-11 (Sept11) B3GNI6 49,663 6.24 5 9 10.2 % 1,25
15 Alpha-enolase (Eno1) P04764 47,098 6.16 4 13 14.1 % −1,1
16 Aconitate hydratase (Aco2) Q9ER34 85,380 7.87 9 33 14.90 % −1,4
(B) Frontal cortex
1 Cytochrome b-c1 complex subunit 2 P32551 48,366 9.16 17 41 40.70 % 2,86
2 Glutamate dehydrogenase 1 P10860 61,377 8.05 26 69 50.40 % 2,37
3 Cell division control protein 42 homolog Q8CFN2 21,245 6.16 3 5 17.80 % −1,75
Fig. 4 Relative changes in the expression of mitochondrial proteins in
the prenatally stressed group treated with tianeptine compared with those
of the prenatally stressed group in the hippocampus (a) and in the frontal
cortex (b). Bioinformatics analysis by Search Tool for the Retrieval of
Interacting Genes/Proteins in the hippocampus (c). The list of the
identified proteins in the hippocampus was subjected to STRING
(version 10) analysis to reveal functional interactions between the
dysregulated proteins. Each node represents a protein, and each edge
represents an association. Stronger associations are represented by
thicker lines
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to upregulate the OGDHC in the hippocampus may have a
beneficial impact on the brain metabolism and on the behavior-
al disturbances observed in prenatally stressed animals.
Remarkably, the dehydrogenases that were affected
by tianeptine are the key rate-limiting enzymes in the
Krebs cycle. Demetrius [34] has noted the key role of
switching between oxidative phosphorylation and gly-
colysis in neurodegeneration, where Krebs cycle activity
is critical. Isocitrate dehydrogenase expression is dimin-
ished in a mouse model of Alzheimer’s disease, and the
administration of an antisense nucleotide targeting β-
amyloid reduced oxidative stress-induced damage, possi-
bly by an increased expression of isocitrate dehydroge-
nase [35].
Chronic tianeptine administration enhanced the expres-
sion of succinate dehydrogenase (SDH), an enzyme impor-
tant not only for the Krebs cycle but also in the mitochon-
drial respiratory chain as an electron-transferring protein
[36]. In addition, SDH activity is one of the most reliable
markers of the efficiency of mitochondrial ATP production,
and altered activity of this enzyme leads to impaired brain
energy metabolism [37]. Most data indicated that chron-
ic stress in rats decreased the activity of SDH in the
brain [38]. Thus, the increase in SDH expression after
tianeptine treatment will have a beneficial impact on
brain metabolism. Moreover, our data are consistent
with previously published reports that chronic treatment
with antidepressants, such as nortriptyline, paroxetine,
or venlafaxine, enhances SDH activity in the brain [8].
In the hippocampus, chronic tianeptine treatment of our
model of depression upregulated not only Krebs cycle
enzymes but also proteins in the respiratory chain including
SDH as well as NADH dehydrogenase iron-sulfur pro-
tein 4 [39].
A further finding of the present study is the observation that
tianeptine administration increased the expression of heat
shock proteins HSP60 and HSP70 in the hippocampus of
prenatally stressed offspring. These conserved proteins fulfill
a protective function, thus eliminating harmful effects, includ-
ing stress. Zlatković [40] showed that HSP70 upregulation
protects the hippocampus from chronic social isolation stress.
HSP70 limits the accumulation and aggregation of misfolded
proteins by directing them to the proteosomal degradation
pathway [41, 42]. HSP60 also has a role in protection from
proteinopathy [43].
Interestingly, in contrast to the hippocampus, the frontal
cortex of adult 3-month-old prenatally stressed offspring was
susceptible to a limited extent to tianeptine action because its
administration changed the expression profile of only three
mitochondrial proteins; among these changes was the upreg-
ulation of glutamate dehydrogenase 1 (GDH1). The link
between depressive-like behavior and reduced GDH1
expression has been observed in the brains of bipolar patients
[44]. GDH1 facilitates the oxidative transamination of
glutamate into alpha-ketoglutarate [45]; thus, the upreg-
ulation of GDH1 by chronic tianeptine treatment may
target the Krebs cycle in the frontal cortex of prenatally
stressed offspring.
Our study also demonstrated that the expression of cyto-
chrome b-c1 complex subunit 2 (also known as complex III or
cytochrome ubiquinone oxidoreductase) was significantly en-
hanced in the mitoproteome in the frontal cortex of prenatally
stressed rats after tianeptine administration. Complex III cat-
alyzes the transfer of electrons from reduced coenzyme Q to
cytochrome c associated with proton pumping to the inter-
membrane space [46]. Up until now, the data relating to the
action of antidepressants on the respiratory chain have been
inconclusive. Hroudova and Fisar [47] showed that chronic
administration of various antidepressants and mood stabilizers
suppressed not only complex III but also complexes I, II, and
IVof the respiratory chain in brain homogenates of untreated
pigs. Investigations in adult male rats revealed that chronic
immobilization stress inhibited the activity of complex III of
the mitochondrial respiratory chain without affecting complex
IV activity, ATP production, or oxygen consumption [48].
Importantly, the impact of tianeptine administration on the
activity of the respiratory chain seems to be dependent on
the brain structure and the duration of treatment [12, 49].
The limitation of our study is that it is a mitoproteomic anal-
ysis after chronic tianeptine treatment in a model of depres-
sion; nevertheless, the present results point to a newmolecular
mechanism of tianeptine that involves the modulation of met-
abolic changes.
In summary, our findings clearly demonstrate that chronic
tianeptine administration effectively attenuated the behavioral
disturbances provoked by early adverse life experiences.
Moreover, 2-DE coupled with mass spectrometry showed
for the first time that chronic tianeptine administration ame-
liorated disruptions in the hippocampal mitoproteome in
an animal model of depression. The key proteins were a
component of the 2-oxoglutarate dehydrogenase com-
plex, isocitrate dehydrogenase [NAD] subunit alpha, en-
ergy production enzymes (succinate dehydrogenase fla-
voprotein subunit and NADH dehydrogenase iron-sulfur
protein 4), and stress-related proteins (HSP60 and HSP70).
Furthermore, in the frontal cortex, we noted the upregulation
of proteins related to the glutamate pathway and the
respiratory chain in prenatally stressed rats chronically
treated with tianeptine. Overall, the directions of tianeptine-
induced changes in the mitoproteome are opposed to
those observed in models of depression or stress-
related disorders.
To conclude, mitochondria may be a critical target for ther-
apeutic interventions in psychiatry, and the improvement of
mitochondrial function could be crucial for the effective treat-
ment of stress-related diseases.
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